Bosutinib

Overview

Bosutinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL288441).

API suppliers (1)

Suppliers of Bosutinib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN Laboratories Private LimitedIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (7 approved US products), the latest listed US patent on Bosutinib expires 27 Aug 2034 and exclusivity 26 Mar 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

Canonical SMILES

CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC

InChIKey

UBPYILGKFZZVDX-UHFFFAOYSA-N